I. Investment Thesis Summary

This report provides a comprehensive fundamental analysis of Nordson Corporation (NDSN), a high-quality industrial compounder with a strong competitive moat, currently navigating a cyclical downturn in key end markets. The company’s core strengths are rooted in a durable business model featuring a significant recurring revenue stream, consistently high profitability, and a disciplined, shareholder-friendly capital allocation strategy. However, these strengths are presently tested by significant organic growth headwinds stemming from weakness in the global electronics and industrial sectors.

The central analytical question is whether Nordson’s strategic initiatives, particularly its significant acquisition-driven pivot towards the less cyclical medical market, can effectively bridge the current organic growth gap and sustain its historically premium valuation.

The bullish perspective centers on Nordson’s resilient financial profile. A revenue base where 57% is derived from recurring parts and consumables provides a stable foundation of cash flow, even as system sales fluctuate.¹ This stability has enabled the company to achieve the status of a “Dividend Aristocrat,” having increased its dividend for 62 consecutive years.² Furthermore, its “Ascend” strategy, highlighted by the recent ~$1.2 billion acquisition of Atrion Corporation, represents a deliberate and potentially transformative shift to increase exposure to the secularly growing medical end market, which could reduce earnings volatility over the long term.⁴

The bearish perspective focuses on the tangible impact of the current cyclical downturn. The company reported a 3% organic sales decline in fiscal 2024, followed by a more pronounced 9% organic decrease in the first quarter of fiscal 2025, driven by persistent weakness in its electronics and industrial-facing segments.¹ This performance contrasts with management’s ambitious long-term targets of 6-8% revenue growth and 10-12% adjusted earnings per share (EPS) growth, creating a “show-me” story for investors.¹ The stock’s historically premium valuation may face pressure if this organic growth weakness persists, and the increased leverage from the Atrion acquisition introduces new financial and integration risks.

Nordson appears best suited for long-term, quality-focused investors with a tolerance for cyclical volatility. The company’s characteristics appeal to those prioritizing dividend growth and the compounding of returns over short-term capital appreciation.

Moving forward, the most critical factors to monitor will be:

• The trajectory of organic growth, particularly in the Advanced Technology Solutions (ATS) and Industrial Precision Solutions (IPS) segments, as an indicator of end-market recovery.
• The successful integration of Atrion, focusing on margin performance and the realization of guided synergies.
• The pace of debt reduction and balance sheet de-leveraging following the acquisition.
• Future capital deployment decisions, specifically the balance between further strategic M&A and shareholder returns through buybacks and dividends.

II. Company Analysis: A Diversified Precision Technology Leader

Business Model and Value Proposition

Nordson Corporation engineers, manufactures, and markets a wide range of differentiated products used for the precision dispensing and processing of adhesives, coatings, sealants, biomaterials, and other fluids.² The company’s core value proposition is rooted in delivering mission-critical technology that enhances its customers’ manufacturing processes. By providing exacting accuracy, process control, and reliability, Nordson’s systems enable customers to achieve significant operational benefits, including reduced material consumption, increased production line speed and efficiency, and improved end-product quality and appearance.¹ This focus on precision and efficiency makes Nordson’s products indispensable components in complex, high-stakes manufacturing environments.

Segment Deep Dive

The company operates through three distinct business segments, each catering to different end markets but unified by a common technological focus on precision fluid management.

• Industrial Precision Solutions (IPS): As Nordson’s largest segment, IPS accounted for 55% of total revenue in fiscal 2024, generating approximately $1.4 billion in sales.¹ This segment provides a broad portfolio of dispensing, coating, and processing equipment for a diverse set of end markets, including consumer non-durable goods (e.g., packaging, diapers), industrial manufacturing, and automotive. Its product lines are critical for applications such as sealing cardboard boxes, bonding automotive components, and applying industrial coatings. IPS is the company’s most profitable segment, boasting a robust operating margin of 34% in fiscal 2024, which underscores its strong market position and the value of its technology.¹
• Medical and Fluid Solutions (MFS): The MFS segment represented 26% of fiscal 2024 revenue, or $695 million.¹ It provides highly engineered, single-use plastic components for fluid management, such as complex medical tubing, balloons, catheters, syringes, and connectors.⁶ These products are critical for medical device OEMs and serve applications in minimally invasive surgery, drug delivery, and bioprocessing. The segment is well-positioned to benefit from long-term secular tailwinds, including an aging global population and the increasing outsourcing of component manufacturing by medical OEMs.¹ The recent agreement to acquire Atrion Corporation for approximately $1.2 billion is a transformative step that will significantly increase the scale, product breadth, and market position of this segment.⁴
• Advanced Technology Solutions (ATS): The ATS segment, which generated 19% of fiscal 2024 revenue ($696 million), is the company’s most technology-intensive and cyclically sensitive business.¹ It provides automated precision dispensing systems, surface treatment technologies, and test and inspection equipment primarily for the electronics manufacturing supply chain.⁶ Its products are used in the production of semiconductors, printed circuit boards (PCBs), and electronic components for end products like mobile phones, PCs, and automotive electronics. While subject to the pronounced cyclicality of the semiconductor industry, ATS is exposed to powerful long-term growth drivers such as 5G, artificial intelligence (AI), and the increasing electronic content in vehicles.¹

Revenue Composition

A granular analysis of Nordson’s revenue composition reveals a resilient and diversified business model that helps mitigate the cyclicality inherent in its end markets.

• By Type: A key structural strength of Nordson’s business model is its “razor/razor-blade” nature. In fiscal 2024, 57% of total revenue was generated from recurring and typically higher-margin sales of parts and consumables, while the remaining 43% came from initial system sales.¹ This large base of recurring revenue is tied to customers’ ongoing production volumes rather than their more volatile capital expenditure cycles. This provides a stable and predictable stream of cash flow that underpins the company’s ability to consistently grow its dividend and fund strategic investments, even during periods of economic softness.
• By End Market: The company’s end-market exposure is well-diversified. For fiscal 2024, the breakdown was: Consumer Non-Durable (25%), Electronics (23%), Medical (21%), Industrial (19%), and a remainder of other markets including automotive and consumer durables (12%).¹ This diversification helps to smooth overall performance, as weakness in one sector can be offset by strength in another. However, the significant combined exposure to the currently challenged electronics and industrial markets has been the primary source of recent organic growth headwinds.
• By Geography: Nordson operates a global model with a direct presence in over 35 countries, aligning its sales and service infrastructure with key manufacturing hubs worldwide.¹ In fiscal 2024, the geographic revenue split was the Americas (44%), Asia Pacific (29%), and Europe (27%).¹ This global footprint allows the company to capitalize on regional growth trends while mitigating risk from a downturn in any single economy.

Table 1: Nordson Segment Overview (Fiscal Year 2024)

Segment	FY2024 Revenue ($M)	% of Total Revenue	FY2024 Operating Margin	Key Products	Key End Markets
Industrial Precision Solutions (IPS)	$1,399	55%	34%	Adhesive/sealant dispensers, coating systems, polymer processing equipment	Consumer Non-Durable, Industrial, Automotive
Medical and Fluid Solutions (MFS)	$695	26%	29%	Medical tubing, balloons, catheters, fluid connectors, single-use components	Medical, High-Tech Industrial
Advanced Technology Solutions (ATS)	$696	19%	19%	Automated fluid dispensing systems, plasma surface treatment, test & inspection equipment	Electronics, Semiconductor, PCB Assembly
Total Company	$2,690	100%	~25%	–	–
Source: Nordson FY2024 Results, February 2025 Investor Presentation.1 Operating margins are as stated in company presentations and may differ from GAAP operating profit due to segment allocations.

III. Industry Dynamics and Competitive Moat

Market Analysis

Nordson operates in several distinct but related industrial technology markets, all of which are characterized by steady long-term growth driven by secular trends in manufacturing.

• Precision Dispensing & Adhesive Equipment: This core market is projected to grow at a compound annual growth rate (CAGR) in the range of 5.6% to 6.2% through the next decade.⁸ Growth is propelled by several key demand drivers: the relentless trend of component miniaturization in the electronics and medical device industries, which requires increasingly precise fluid application; the shift toward lightweight and composite materials in the automotive and aerospace sectors, which favors adhesive bonding over mechanical fasteners; and the widespread adoption of automation and robotics in manufacturing to enhance efficiency and quality.⁹
• Industrial Coating Equipment: The market for industrial coating equipment is forecast to expand at a similar CAGR, estimated between 5.3% and 6.4%.¹³ This market is fueled by the need for durable, protective, and aesthetically pleasing finishes in major industries such as automotive, aerospace, and construction. The rise of electric vehicles (EVs), which require specialized coatings for batteries and components, is a significant emerging driver.¹³
• Market Cyclicality: Despite these positive long-term trends, Nordson’s markets are inherently cyclical and are closely tied to global industrial production, capital investment cycles, and overall economic health. The Advanced Technology Solutions segment is particularly exposed to the semiconductor capital equipment market, which is known for its pronounced boom-and-bust cycles driven by technology transitions and inventory adjustments.¹⁷ Similarly, the automotive end market, a key consumer for the IPS segment, exhibits strong seasonal and cyclical patterns influenced by consumer confidence and interest rates.²⁰

Competitive Landscape

The precision dispensing and coating markets are fragmented but include a number of large, well-capitalized global players. Nordson’s primary publicly traded competitors, against which it is most frequently benchmarked, are Graco Inc. (GGG), Dover Corporation (DOV), and Illinois Tool Works (ITW).²²

• In the Industrial Precision Solutions segment, Nordson competes directly with Graco, which has a formidable presence in fluid handling and industrial finishing systems, as well as with various divisions within ITW that serve the automotive and general industrial markets.²²
• In the Medical and Fluid Solutions segment, competitors range from specialized fluid component manufacturers to divisions of larger diversified industrial companies like IDEX Corporation and Parker-Hannifin.²³
• In the Advanced Technology Solutions segment, Nordson faces competition from specialized electronics assembly and inspection equipment providers, including divisions of Dover and ITW’s Test & Measurement and Electronics segment.²³

Sources of Competitive Advantage

Nordson has established a strong and durable competitive moat, which allows it to generate superior returns and defend its market share. The key sources of this advantage are:

• Technological Leadership and Patents: Nordson’s business is built on a foundation of proprietary technology protected by a robust patent portfolio. The company holds over 95 active patents and has an extensive list of patents covering its specific product lines in fluid dispensing, conformal coating, and plasma treatment.² This continuous innovation creates differentiated products that competitors cannot easily replicate, allowing Nordson to command premium pricing.
• High Customer Switching Costs: This is arguably Nordson’s most powerful competitive advantage. Its dispensing systems are deeply embedded and integrated into customers’ mission-critical manufacturing lines. For a customer, the cost of the Nordson system is a small fraction of the total value of their end product (e.g., a smartphone or a medical device). However, the cost of a failure in that system—leading to production line stoppages, product defects, or even recalls—is immense. Consequently, once a Nordson system is designed into a production line and validated, the risk, cost, and time required to re-qualify a competitor’s system create a powerful incentive to stay with the incumbent supplier. This customer inertia is further reinforced by the “razor/razor-blade” model, which locks customers into purchasing Nordson’s proprietary, high-margin consumables and replacement parts.
• Global Direct Sales and Service Network: Nordson markets its products through a direct sales and service network in more than 35 countries.¹ This global footprint is a significant competitive differentiator. It allows the company to foster deep, consultative relationships with its customers, providing the application expertise and technical support necessary to solve complex manufacturing challenges. This extensive network is difficult and costly for smaller competitors or new entrants to replicate.
• Significant Barriers to Entry: The combination of the factors above—the need for substantial and sustained R&D investment, a protective wall of intellectual property, high customer switching costs, and the requirement of a global service infrastructure—creates formidable barriers to entry that protect Nordson’s market position from new competitors.

IV. Financial Performance and Historical Growth Trajectory

An examination of Nordson’s financial history reveals a track record of consistent growth, high profitability, and strong cash generation, hallmarks of a high-quality industrial compounder.

Long-Term Trend Analysis

• Revenue Growth: Over the five-year period from fiscal 2019 to 2024, Nordson achieved an average annual sales growth of 6%.² A more detailed look at recent years shows total revenue growth of 9.7% in FY2022, 1.5% in FY2023, and 2.3% in FY2024.⁶ However, a critical distinction must be made between total and organic growth. In fiscal 2024, for instance, the 2.3% top-line growth was entirely driven by a 5% contribution from acquisitions, which masked a 3% decline in organic volume.⁴ This highlights the company’s increasing reliance on M&A to achieve growth in the face of cyclical end-market headwinds.
• Profitability Trends: Nordson’s profitability metrics are consistently strong and represent a core pillar of its investment case.

• Gross Margins: The company has maintained impressive gross margins, averaging 54.2% between 2019 and 2024.² In fiscal 2024, the gross margin was 55.2%, an improvement from 54.2% in the prior year, demonstrating effective cost control and pricing power despite inflationary pressures.⁶
• EBITDA Margins: EBITDA margins are a standout feature, averaging 30.1% from 2019-2024.² In fiscal 2024, the company achieved a record EBITDA of $849 million, representing a margin of 32% of sales, up from 31% in fiscal 2023.⁴ This expansion of margins during a period of negative organic growth suggests a favorable sales mix (more high-margin consumables) and disciplined operational execution.
• Returns on Capital: The company has a history of generating strong returns for shareholders. The 2023 proxy statement highlighted a 10-year total shareholder return of 322%.³¹ Analyzing trends in Return on Invested Capital (ROIC) and Return on Equity (ROE) consistently shows that the company generates returns well in excess of its cost of capital, a key indicator of value creation.

Cash Flow Profile

Nordson exhibits an exceptional ability to convert earnings into cash.

• Free Cash Flow (FCF) Generation: Between fiscal 2019 and 2024, the company generated over $2.8 billion in free cash flow before dividends.²
• Cash Conversion: This FCF generation represents an average conversion rate of 113% of net income over the same period, indicating very high-quality earnings.² This strong performance continued in fiscal 2024, with a free cash flow conversion rate of 105% of net income.⁴ The most recent quarter (Q3 FY25) showed an even stronger conversion of 180%.³² This robust and reliable cash flow is the lifeblood of the company, funding its entire capital allocation program of dividends, M&A, and share repurchases.

Peer Benchmarking

Placing Nordson’s financial performance in the context of its direct, high-quality peers is essential for a complete analysis. The company competes with other well-regarded industrial manufacturers such as Graco (GGG), Dover (DOV), and Illinois Tool Works (ITW). A comparative analysis reveals that while Nordson’s profitability is elite, its recent organic growth has lagged some competitors, creating a key point of debate for its valuation.

Table 2: Key Financial Metrics Comparison (Trailing Twelve Months)

Metric	Nordson (NDSN)	Graco (GGG)	Dover (DOV)	Illinois Tool Works (ITW)
Revenue Growth (YoY)	4.5%	**	**	**
Organic Growth (YoY)	-3.1% (9 mos. ended 7/31/25)	**	**	**
Gross Margin %	54.7% (9 mos. ended 7/31/25)	**	**	**
EBITDA Margin %	32.0% (FY2024)	**	**	**
Operating Margin %	24.4% (9 mos. ended 7/31/25)	**	**	25.0% (FY2024, Test & M.)
Net Margin %	16.3%	**	**	**
Return on Equity %	19.5%	**	**	**
FCF Conversion %	105% (FY2024)	**	13.5% of Revenue (FY2024)	**
Note: Data for NDSN sourced from company filings.4 Peer data is illustrative and requires sourcing from their respective financial reports. TTM data can vary based on reporting periods. The data provided in the source material for peers was insufficient to fully populate this comparative table.

V. Navigating the Cycle: Recent Challenges and Headwinds (2023-Present)

Over the past two years, Nordson’s performance has been defined by the challenge of navigating a significant cyclical downturn in its core end markets, which has overshadowed its acquisition-driven headline growth and strong profitability.

End-Market Weakness

The primary headwind has been a broad-based slowdown in global industrial activity, with a particularly acute impact on the electronics sector. This is not a challenge unique to Nordson but reflects a wider industry trend. The company’s financial results clearly illustrate this pressure:

• In the fourth quarter of fiscal 2024, the company reported a 3% organic sales decline, driven by weakness in industrial coatings, polymer processing, and precision agriculture product lines.⁴
• This weakness accelerated into the first quarter of fiscal 2025, which saw a sharp 9% year-over-year organic sales decrease. Management attributed this decline to continued softness in polymer processing, industrial coatings, electronics dispense, and certain medical product lines.¹

This period of negative organic growth stands in contrast to the company’s long-term historical average and its stated strategic goals, highlighting the depth of the current cyclical trough.

Segment-Specific Impacts

The downturn has not been uniform across all of Nordson’s businesses, with the industrial and electronics-focused segments bearing the brunt of the slowdown.

• Industrial Precision Solutions (IPS): This segment, the company’s largest, experienced a 5% organic sales decline in Q4 2024.⁴ For the first nine months of fiscal 2025, IPS sales were down 6.0% year-over-year, with a 5.7% organic decline, reflecting broad weakness in industrial capital spending.³⁴
• Medical and Fluid Solutions (MFS): While often seen as a source of stability, this segment has not been entirely immune. It posted a 3% organic sales decrease in Q4 2024, driven by softness in medical interventional solutions.⁴ For the first nine months of fiscal 2025, organic sales were down 7.1%, though recent results have shown improvement, with organic sales up 4% in Q3 2025 when excluding a pending divestiture.³²
• Advanced Technology Solutions (ATS): This segment’s performance reflects the deep cyclicality of the electronics market. After a period of weakness, it has shown signs of recovery, posting 4% organic growth in Q4 2024 and a robust 15% organic sales increase in Q3 2025, driven by a rebound in electronics dispense product lines.⁴ This volatility underscores the segment’s sensitivity to semiconductor and electronics capital spending cycles.

Macroeconomic and Geographic Factors

Broader macroeconomic pressures have compounded the end-market challenges. Persistently high interest rates globally have likely caused customers to defer or delay large capital equipment purchases, impacting Nordson’s system sales. While the company has successfully managed cost inflation to protect its gross margins, the overarching concern of a potential industrial recession has created a cautious spending environment.

Geographically, the performance has been mixed. For the nine months ended July 31, 2025, the Asia Pacific region was a source of strength, with sales growing 16.2%.³⁴ This was driven by the recovery in the electronics market. In contrast, Europe remained a significant source of weakness, with sales declining 2.6% over the same period, reflecting the sluggish industrial environment in that region.³⁴

VI. Pathways to Growth: Strategic Initiatives and Opportunities

Despite the near-term cyclical headwinds, Nordson is actively pursuing a multi-faceted strategy aimed at driving long-term profitable growth. This strategy combines organic innovation, operational excellence, and disciplined strategic acquisitions.

Organic Growth Drivers and Secular Trends

Nordson’s product portfolio is well-aligned with several powerful, long-term secular growth trends that should provide a tailwind for organic growth beyond the current cycle. These include:

• Automation and Industry 4.0: The global push for greater manufacturing efficiency, precision, and connectivity drives demand for Nordson’s automated dispensing and quality control systems.¹⁰
• Electronics Miniaturization and Complexity: The increasing complexity and decreasing size of electronic components in smartphones, wearables, and high-performance computing require the ultra-precise application of fluids that Nordson’s ATS systems provide.¹
• Vehicle Electrification: The transition to EVs creates significant new content opportunities. EVs require novel dispensing applications for battery manufacturing (e.g., thermal interface materials), power electronics, and lightweight component bonding.¹
• Medical Technology Advancement: Growth in the medical device market, driven by an aging population and the shift toward minimally invasive surgical techniques, fuels demand for the high-precision components manufactured by the MFS segment.¹

To capitalize on these trends, Nordson consistently invests in research and development. The company’s R&D expenditures have averaged approximately 2.5% of sales between fiscal 2020 and 2024, funding the innovation pipeline required to maintain its technological leadership.³⁵

The “Ascend” Strategy and M&A

Management has articulated a clear long-term growth plan called the “Ascend” strategy, with stated financial targets for the period 2025-2029. The company is aiming for 6-8% average annual revenue growth and 10-12% average annual adjusted EPS growth.¹ This growth is expected to be balanced, with a “growth algorithm” targeting 3-4% from organic initiatives and 3-4% from strategic mergers and acquisitions.¹

The cornerstone of the M&A component of this strategy is the recently announced agreement to acquire Atrion Corporation for approximately $1.2 billion in cash.⁴ Atrion is a manufacturer of proprietary medical products for infusion and cardiovascular technologies, with approximately $169 million in 2023 revenue.⁵ This acquisition is strategically significant for several reasons:

1. Scale and Diversification: It materially increases the scale of the MFS segment and diversifies Nordson’s portfolio further into the less cyclical and secularly growing medical market.
2. New Market Access: It expands Nordson’s medical portfolio into new, high-value therapies and adds three FDA-registered manufacturing facilities in the U.S..⁵
3. Financial Impact: The acquisition was valued at approximately 15 times Atrion’s 2024 estimated EBITDA, including expected synergies, and is anticipated to be accretive to Nordson’s earnings.⁵ This move is a tangible execution of the “Ascend” strategy to re-weight the company’s portfolio towards more stable growth markets.

Operational Excellence: NBS NEXT

Underpinning the growth strategy is an internal continuous improvement framework known as “NBS NEXT” (Nordson Business System). This initiative is focused on driving profitable growth by systematically identifying and investing disproportionately in the best growth opportunities across the company’s portfolio. It emphasizes an entrepreneurial, division-led organizational structure that keeps decision-making close to the customer while maintaining accountability.¹ This framework is the primary tool management is using to drive margin expansion and improve returns on capital over time.

VII. Capital Allocation and Balance Sheet Management

Nordson employs a disciplined and well-defined capital allocation strategy characteristic of a mature, high-quality industrial company. Management’s approach prioritizes funding internal growth and providing consistent returns to shareholders while retaining the financial flexibility for strategic acquisitions.

Deployment Strategy

The company has a clear hierarchy for capital deployment, which it has communicated to investors ¹:

1. Fund Organic Growth: The first priority is to reinvest in the business through capital expenditures and R&D to support innovation and growth.
2. Return Capital to Shareholders: This is achieved through a reliable and growing dividend, supplemented by share repurchases intended, at a minimum, to offset dilution from equity compensation.
3. Strategic Capital Deployment: Remaining cash flow is allocated to strategic M&A, debt reduction, and opportunistic share repurchases. The company projects it will have approximately $2.8 billion available for this strategic deployment through 2029.¹

Shareholder Returns

• Dividends: The dividend is a cornerstone of Nordson’s value proposition for shareholders. The company has an exceptional track record, having increased its annual dividend for 62 consecutive years, earning it a place among the elite “Dividend Aristocrats”.² The most recent increase, announced in August 2025, was 5%.² The sustainability of this dividend growth is supported by the company’s strong free cash flow generation and a historically manageable payout ratio.
• Share Repurchases: Nordson actively uses share buybacks as part of its capital return program. In the third quarter of fiscal 2025, the Board of Directors approved a new $500 million share repurchase authorization, signaling continued commitment to this method of returning capital.³²

Financial Health

Nordson has historically maintained a strong and conservative balance sheet. At the end of fiscal 2022, the company’s leverage ratio (based on trailing 12-month EBITDA) was a very low 0.7x.³¹ However, the ~$1.2 billion all-cash acquisition of Atrion will be funded with debt, which will significantly increase the company’s leverage in the near term. A key focus for the investment community will be management’s plan and timeline for reducing this debt and returning the balance sheet to its historical strength. The company’s powerful free cash flow generation should provide ample capacity to service this increased debt load and de-lever over the next several years.

VIII. Management Quality and Corporate Governance

Leadership Assessment

Nordson’s senior leadership team, led by President and CEO Sundaram Nagarajan, has established a clear, multi-year strategic framework designed to position the company for its next phase of growth. The “Ascend” strategy and the “NBS NEXT” operational framework provide a transparent roadmap for investors to evaluate management’s execution. The team has demonstrated a willingness to make bold, strategic moves, as evidenced by the large-scale acquisition of Atrion. The ultimate measure of this team’s success will be its ability to deliver on its ambitious long-term financial targets, particularly the goal of achieving 10-12% adjusted EPS growth, which will require a successful integration of Atrion and a re-acceleration of organic growth in its core businesses.¹

Communication and Transparency

Management’s communication with the investment community via quarterly earnings calls and investor presentations is generally transparent and professional.² They have been forthcoming about the cyclical challenges impacting the business, acknowledging the “dynamic demand conditions” and softness in specific product lines while also highlighting areas of strength and strategic progress.¹ The clear articulation of long-term financial targets and the underlying growth algorithm provides a useful benchmark for holding management accountable.

Alignment with Shareholders

• Insider Ownership: Analysis of market data indicates that insider ownership at Nordson is relatively low, at approximately 0.8% of shares outstanding.²³ While not necessarily a red flag, this is lower than some industrial peers and is a factor to consider when assessing the direct alignment of management’s financial interests with those of public shareholders.
• Executive Compensation: A review of the company’s proxy statements reveals an executive compensation structure that incorporates both short-term and long-term incentives tied to key performance metrics. These typically include financial objectives such as revenue growth and earnings, as well as strategic goals. The structure is designed to reward performance that drives long-term shareholder value.
• Board of Directors and Governance: Nordson’s Board of Directors exhibits strong governance characteristics. As of early 2025, the board was 50% diverse (by gender, race, or ethnicity), and 9 out of 10 directors were independent.¹ The average tenure of 6 years suggests a healthy balance of experience and fresh perspectives.¹ This structure provides a framework for robust oversight and effective governance.

IX. Valuation Analysis

Assessing Nordson’s valuation requires comparing its current multiples against its own historical ranges and against its direct peer group. This analysis suggests that while the company’s valuation has moderated from recent highs, it continues to trade at a premium, reflecting its high-quality business characteristics.

Multiples Analysis

Based on its financial performance and stock price, Nordson’s valuation can be assessed using several key multiples. A comparison of these current multiples to their historical averages provides context on whether the stock is trading at a premium or discount to its typical range. The recent decline in the stock price from its 52-week high of over $266 has led to a compression in these multiples, reflecting market concerns over the organic growth slowdown.³⁸

Relative Valuation

Nordson has consistently commanded a premium valuation relative to the broader industrial sector, a function of its superior profitability, high returns on capital, and consistent growth. The more critical comparison, however, is against its direct, high-quality peers like Graco (GGG), Dover (DOV), and Illinois Tool Works (ITW), which also exhibit strong financial characteristics. This peer benchmark is essential to determine if the degree of Nordson’s premium is justified given its current performance. For example, if Nordson trades at a significantly higher P/E ratio than Graco while posting weaker organic growth, its relative valuation may be considered stretched.

Table 3: Valuation Multiples (Current vs. Historical and Peers)

Metric	NDSN (Current)	NDSN (5-Yr Avg)	GGG (Current)	DOV (Current)	ITW (Current)
P/E Ratio (TTM)	29.00	**	29.97	10.04	22.91
EV/EBITDA (TTM)	**	**	**	**	**
Price / Sales (TTM)	4.82	**	**	**	**
Dividend Yield	1.40%	**	**	**	**
Source: Market data as of early October 2025.23 Historical averages and certain peer metrics require external data sources. TTM (Trailing Twelve Months) multiples are subject to change with market price and earnings updates.

Valuation Narrative

The current valuation of Nordson stock reflects a tension between its long-term quality and its near-term cyclical challenges.

• The Bullish Argument (Justifying the Valuation): An investor taking a positive view would argue that the market is correctly “looking through” the temporary, cyclical downturn in the electronics and industrial markets. The current valuation is based on Nordson’s normalized, long-term earnings power, which is enhanced by the strategic addition of the stable, high-growth Atrion medical business. The premium multiple is warranted by the company’s best-in-class EBITDA margins, strong free cash flow conversion, and its durable competitive moat built on technology and high switching costs.
• The Bearish Argument (Suggesting Overvaluation): A more cautious investor would argue that the current valuation does not adequately price in the risk of a deeper or more prolonged downturn. The negative organic growth figures are a significant concern that undermines the growth component of the investment thesis. From this perspective, the premium valuation is a relic of a previous, higher-growth environment and is vulnerable to further compression if the company fails to demonstrate a clear path back to positive organic growth in its core segments.

X. Key Risks and Considerations

A comprehensive analysis of Nordson requires a thorough evaluation of the potential risks to the investment thesis. These can be categorized into company-specific, industry-related, and broader financial and macroeconomic risks.

Company-Specific Risks

• M&A Integration Risk: The acquisition of Atrion is large and strategically important, but it is not without risk. A failure to smoothly integrate Atrion’s operations, retain key talent, and achieve the projected cost and revenue synergies could result in a failure to earn an adequate return on the significant capital invested, negatively impacting future earnings and shareholder value.
• Technology Obsolescence: Nordson’s competitive advantage is heavily reliant on its technological leadership. The company must continue to invest effectively in R&D to innovate and stay ahead of both existing competitors and potentially disruptive new technologies in precision dispensing, coating, and fluid management.
• Execution Risk: Management has set ambitious financial targets for 2029. Given the current negative organic growth, there is a significant risk that the company may not achieve these goals, which could lead to a loss of investor confidence and a de-rating of the stock’s valuation multiple.

Industry and Cyclical Risks

• End-Market Cyclicality: This is the most prominent near-term risk. Nordson’s financial performance is intrinsically linked to the economic health and capital spending cycles of the global electronics, automotive, and general industrial markets. A prolonged global recession or a deeper-than-expected downturn in the semiconductor industry would have a direct and material negative impact on the company’s revenue and profitability.
• Customer Concentration: While its customer base is diverse, the loss of or a significant reduction in business from a major customer in a key market, such as a large smartphone manufacturer in the ATS segment, could have a disproportionate impact on results.

Financial and Macroeconomic Risks

• Financial Leverage: The Atrion acquisition was financed with debt, which has increased the company’s financial leverage. While the company’s cash flow is strong, higher debt levels make it more vulnerable to an economic downturn or a sharp rise in interest rates, which could increase interest expense and constrain financial flexibility.
• Currency Fluctuations: As a global company with 56% of its revenue generated outside the Americas, Nordson is exposed to foreign currency risk.¹ A significant strengthening of the U.S. dollar relative to other currencies (such as the Euro or Japanese Yen) would translate into lower reported revenue and earnings.
• Geopolitical and Regulatory Risks: Nordson’s significant presence in the Asia Pacific region (29% of sales) exposes it to geopolitical risks, including trade tensions and tariffs, which could disrupt supply chains or impact customer demand.¹ Changes in environmental or medical device regulations in key markets could also increase compliance costs or require changes to products and manufacturing processes.

Frequently Asked Questions

Earnings & Business Cycle

• Are earnings at a cyclical high or cyclical low? Earnings appear to be at or near a cyclical low. The company has recently reported organic sales declines, including a 3% decrease for fiscal year 2024 and a more pronounced 9% drop in the first quarter of fiscal 2025. This weakness is concentrated in the industrial and electronics-facing segments, indicating a downturn in those key end markets. While the Advanced Technology Solutions segment has shown recent signs of recovery, the overall trend points toward a cyclical trough.  
• Are earnings driven primarily by the external environment or internal company actions? The recent downward trend in earnings is driven primarily by the external environment, specifically the cyclical weakness in global electronics and industrial markets. However, the company’s ability to maintain high profitability margins (32% EBITDA margin in FY2024) even during this downturn is a result of internal actions, such as its “NBS Next” operational excellence framework and disciplined cost management.  
• How stable are revenues? How much do they fluctuate with the economy? Revenues have a significant stable component, which helps cushion the impact of economic fluctuations. In fiscal 2024, 57% of revenue came from recurring sales of parts and consumables, which are tied to customers’ ongoing production volumes rather than their more volatile capital spending cycles. The remaining 43% from system sales is more cyclical and fluctuates with the broader economy and industrial capital investment. The recent organic sales declines demonstrate this cyclicality.  
• Has the business environment changed recently? Yes, the business environment has weakened significantly over the past two years. The company is navigating a broad-based slowdown in global industrial activity, with a particularly sharp downturn in the electronics sector. This has resulted in negative organic growth, a notable change from the company’s long-term historical performance.  

Business Model & Industry

• Can this business be easily understood? Yes, the fundamental business model is straightforward and can be understood relatively easily. The company operates on a “razor/razor-blade” model, selling mission-critical precision dispensing systems (the “razor”) and then generating a recurring stream of revenue from the necessary, proprietary parts and consumables (the “blades”). It operates through three distinct segments serving the industrial, medical, and advanced technology markets.  
• How profitable is this industry? Are there a lot of competitors? What are the barriers to entry? The precision technology industry is highly profitable, attracting several large, well-capitalized competitors such as Graco (GGG), Dover (DOV), and Illinois Tool Works (ITW). Barriers to entry are formidable and include:
  • Proprietary Technology: A significant portfolio of patents protects the company’s innovative products.  
  • High Customer Switching Costs: Equipment is deeply integrated into customers’ critical manufacturing lines, making it risky and expensive to switch to a competitor.  
  • Global Direct Sales and Service Network: A direct presence in over 35 countries is difficult for new entrants to replicate.  
• What is the nature of competition? Do brand names matter? What are the customers switching costs? Competition is based on technology, precision, reliability, and service rather than price. Brand names and reputation are critical, as customers rely on them for mission-critical applications. Nordson’s brands include Asymtek, Dage, and EFD. Customer switching costs are very high and form a key part of the company’s competitive moat. Once a system is designed into a production line and validated, the operational risk, time, and cost required to qualify a new supplier are prohibitive for the customer.  
• Can this company be undermined by foreign, low-cost labor? It is unlikely. Nordson’s competitive advantage is built on proprietary technology, engineering expertise, and precision manufacturing, not on labor costs. The value it provides comes from enhancing customers’ automated manufacturing processes, which is a knowledge-intensive, high-value-add activity that cannot be easily replicated by low-cost labor.  
• Do brands matter in the business? Or is this a commodity producer? Brands are very important. The company is a producer of highly differentiated, engineered solutions, not a commodity producer. Customers rely on trusted brands for mission-critical applications where equipment failure would be catastrophic to their own production.  
• Outlook for the company’s products and services? How big will this market be? Is it growing? Shrinking? Domestic or international? The outlook for the company’s key international markets is positive, with steady long-term growth projected:
  • Fluid & Adhesive Dispensing Equipment: This global market was valued between $8.5 billion and $9 billion in 2022-2025 and is projected to grow at a CAGR of 5.6% to 6.7% through the next decade.  
  • Industrial Coating Equipment: This global market was valued between $16.6 billion and $23.1 billion in 2021-2024 and is forecast to grow at a CAGR of 5.3% to 6.4%.  

Financial Health & Profitability

• How profitable is this business? What is the return on capital invested? Return on equity? The business is highly profitable, consistently generating best-in-class margins.
  1. Profitability: Average EBITDA margins were 30.1% from 2019-2024, reaching a record 32% in fiscal 2024. Average gross margins for the same period were 54.2%.  
  2. Returns: The company’s Return on Equity (ROE) is 19.5%. It has a history of generating a Return on Invested Capital (ROIC) that exceeds its cost of capital.  
• How much free cash flow does the business generate? How does management use this free cash flow? What is their philosophy? Nordson is a strong generator of free cash flow (FCF), producing over $2.8 billion before dividends between 2019 and 2024. In fiscal 2024, FCF was $492 million. Management’s capital deployment philosophy is clear and prioritized :
  1. Fund organic growth (R&D, CapEx).
  2. Return capital to shareholders via dividends and routine share repurchases.
  3. Use remaining capital for strategic M&A, debt reduction, and additional share buybacks.
• How CapEx hungry is this business? What % of cash from operations must be spent on CapEx to sustain the business? The business is not excessively capital expenditure-hungry. In fiscal 2022, for example, additions to property, plant, and equipment represented about 10% of net cash provided by operating activities. Over the last five years, the company invested approximately $800 million in combined capital expenditures and product development.  
• Is net income diverging from cash from operations? No, in fact, cash from operations is consistently stronger than net income. The company has an average free cash flow conversion rate of 113% of net income (2019-2024). This indicates very high-quality earnings and conservative accounting practices.  
• How conservative is the company’s accounting? Are they over- or under-stating earnings? The company’s accounting appears to be conservative. The consistently high rate of cash flow conversion (105% in FY2024, 180% in Q3 FY2025) suggests that reported net income is a reliable and potentially understated proxy for the company’s true cash-generating power.  
• Has the company recently changed accounting policies? No significant accounting policy changes have been recently implemented. The company has noted it is evaluating the future impact of ASU 2024-03, which it anticipates adopting in fiscal 2028.  

Capital Allocation & Shareholder Actions

• Is the company buying back shares? Paying dividends? Yes, the company does both consistently.
  • Dividends: Nordson is a “Dividend Aristocrat,” having increased its dividend for 62 consecutive years. The most recent increase was 5%.  
  • Buybacks: The Board of Directors approved a new $500 million share repurchase authorization in the third quarter of fiscal 2025.  
• Does the company issue large amounts of new shares to insiders? Information on specific share issuance to insiders is detailed in the company’s proxy statements. Share repurchases are used, at a minimum, to offset dilution from equity compensation plans.  
• How many options / shares is the management issuing to insiders? Is it more than 10% of net income? Details regarding the value of stock and option awards are available in the company’s definitive proxy statement. Based on fiscal 2024 net income of $467 million, the value of these awards would need to exceed $46.7 million to be more than 10%.  

Recent Company-Specific Events

• Has the company made any significant acquisitions recently? Yes, Nordson recently announced a definitive agreement to acquire Atrion Corporation, a medical technology company, for approximately $1.2 billion in cash. This is a significant strategic move to expand its Medical and Fluid Solutions segment.  
• What are the recent news on the company? Recent corporate news includes:
  • Reporting third-quarter fiscal 2025 results, which showed a 12% year-over-year sales increase driven by acquisitions and a recovery in the electronics segment.  
  • Increasing the dividend by 5%, marking the 62nd consecutive year of increases.  
  • Completing the divestiture of select contract manufacturing product lines to narrow the focus of its medical segment on proprietary components.  
• Recent changes in the business, new markets, new production facilities, what’s changed recently? New management? The most significant recent changes include the large acquisition of Atrion to expand into new medical therapies and the divestiture of non-core contract manufacturing assets. In April 2025, the company also announced a leadership transition for its Medical and Fluid Solutions segment.  

Management & Governance

• What are the motivations of management? Do they own a lot of stock and options? Management’s motivations are guided by the “Ascend” strategy, which has clear financial targets of 6-8% average annual revenue growth and 10-12% adjusted EPS growth through 2029. Executive compensation is structured to reward the achievement of these goals. Insider ownership is approximately 0.8% of outstanding shares.  
• What is the compensation policy of directors and management? The compensation policy for directors and management is detailed in the company’s proxy statement. It is designed to align executive interests with long-term shareholder value by tying a significant portion of compensation to the company’s financial and strategic performance.  

Risks & Stock Information

• What factors would cause the stock to decline? Are these factors controlled by the company or the external environment? The primary risk factors are a mix of external and internal variables:
  • External: A deeper or more prolonged cyclical downturn in key end markets (electronics, automotive, industrial) is the most significant near-term risk and is outside the company’s control.  
  • Internal: Company-controlled risks include the failure to successfully integrate the large Atrion acquisition or an inability to execute on the stated “Ascend” growth strategy.  
• What is the risk of a catastrophic loss on this investment? What is the chance of a total loss? The risk of a catastrophic or total loss is extremely low. The company has a durable business model with high recurring revenue, a long history of high profitability, strong cash flow, and a conservative balance sheet. It is a well-established market leader and a Dividend Aristocrat. The primary investment risk is share price volatility and potential valuation compression due to economic cycles, not fundamental business failure.  
• Does the company have assets that are not fully recognized in the balance sheet? Yes. Significant intangible assets such as brand reputation, deep customer relationships built on high switching costs, and a valuable patent portfolio (over 95 active patents) are sources of economic value that are not fully reflected on the balance sheet under standard accounting rules.  
• What off B/S liabilities does the company have? Information regarding off-balance sheet liabilities was not available in the materials reviewed. This information would be detailed in the company’s full 10-K filing with the SEC.  
• Is the stock an ADR? What are the ADR fees? No, the stock is not an American Depositary Receipt (ADR). Nordson Corporation is a U.S. company headquartered in Ohio, and its common stock trades directly on the NASDAQ exchange under the ticker symbol NDSN. Therefore, there are no ADR fees.  

Works cited

1. Investor Presentation, accessed October 8, 2025, https://s202.q4cdn.com/528247721/files/doc_financials/2025/q1/FY25-Nordson-Investor-Presentation-2-19-25.pdf
2. Nordson Corporation – Investor Relations, accessed October 8, 2025, https://www.nordson.com/en/about-us/investor-relations
3. Nordson Corporation Announces Earnings Release and Webcast for Third Quarter Fiscal Year 2025, accessed October 8, 2025, https://www.nordson.com/en/About-Us/Newsroom/Corporate-News/Nordson-Corporation-Announces-Earnings-Release-and-Webcast-for-Third-Quarter-Fiscal-Year-2025
4. Nordson Corporation Reports Fourth Quarter and Fiscal Year 2024 Results, accessed October 8, 2025, https://www.nordson.com/en/about-us/newsroom/corporate-news/nordson-corporation-reports-fourth-quarter-and-fiscal-year-2024-results
5. Nordson Corporation Announces Agreement to Acquire Atrion Corporation, a Market Leader in Medical Infusion and Cardiovascular Technologies, accessed October 8, 2025, https://www.nordson.com/en/about-us/newsroom/corporate-news/nordson-corporation-announces-agreement-to-acquire-atrion-corporation
6. ndsn-20241031 – SEC.gov, accessed October 8, 2025, https://www.sec.gov/Archives/edgar/data/72331/000007233124000177/ndsn-20241031.htm
7. FORM 10-K NORDSON CORPORATION – SEC.gov, accessed October 8, 2025, https://www.sec.gov/Archives/edgar/data/72331/000095015203000680/l97324ae10vkxpdfy.pdf
8. Fluid Dispensing Equipment Market | Industry Report, 2033, accessed October 8, 2025, https://www.grandviewresearch.com/industry-analysis/fluid-dispensing-equipment-market
9. Fluid Dispensing Equipment Market Poised for Accelerated – openPR.com, accessed October 8, 2025, https://www.openpr.com/news/4210627/fluid-dispensing-equipment-market-poised-for-accelerated
10. Dispensing Systems Market | Size, Share, Growth | 2024 – 2030, accessed October 8, 2025, https://virtuemarketresearch.com/report/dispensing-systems-market
11. Adhesive Dispensing Equipment Market Size, Share | 2033 – Allied Market Research, accessed October 8, 2025, https://www.alliedmarketresearch.com/adhesive-dispensing-equipment-market-A138160
12. Adhesive Equipment Market Size, Share and Report 2033 – IMARC Group, accessed October 8, 2025, https://www.imarcgroup.com/adhesive-equipment-market
13. Coating Equipment Market Size And Analysis Report, 2030 – Grand View Research, accessed October 8, 2025, https://www.grandviewresearch.com/industry-analysis/coating-equipment-market
14. Coating Equipment Market Size. Growth, Share & Forecast, accessed October 8, 2025, https://www.verifiedmarketresearch.com/product/global-coating-equipment-market-size-and-forecast/
15. Coat Equipment Market Size, Share | Industry Forecast [2032] – Fortune Business Insights, accessed October 8, 2025, https://www.fortunebusinessinsights.com/coat-equipment-market-108485
16. Coating Equipment Market, Industry Size Forecast [Latest], accessed October 8, 2025, https://www.marketsandmarkets.com/Market-Reports/coating-equipment-market-37434769.html
17. Semiconductor Capital Equipment Market Size to Hit USD 210.58 …, accessed October 8, 2025, https://www.precedenceresearch.com/semiconductor-capital-equipment-market
18. THE SEMICONDUCTOR CYCLE – Regions Bank, accessed October 8, 2025, https://www.regions.com/-/media/pdfs/AssetManagement-The-Semiconductor-Cycle.pdf
19. Investing Throughout Semiconductor Market Cycles – Simply Wall St, accessed October 8, 2025, https://simplywall.st/article/investing-throughout-semiconductor-market-cycles
20. How Important Are Seasonal Trends in the Automotive Sector?, accessed October 8, 2025, https://www.investopedia.com/ask/answers/041715/how-important-are-seasonal-trends-automotive-sector.asp
21. 2025 economic trends impacting the auto industry outlook – Agency Forward® – Nationwide, accessed October 8, 2025, https://agentblog.nationwide.com/market-trends/economic-commentary/auto-industry-economic-trends/
22. Top Nordson Competitors and Alternatives | Craft.co, accessed October 8, 2025, https://craft.co/nordson/competitors
23. Nordson (NDSN) Competitors and Alternatives 2025 – MarketBeat, accessed October 8, 2025, https://www.marketbeat.com/stocks/NASDAQ/NDSN/competitors-and-alternatives/
24. Top Nordson EFD Competitors and Alternatives | Craft.co, accessed October 8, 2025, https://craft.co/nordson-efd/competitors
25. Fluid Dispensing Systems Market Companies – SkyQuest Technology Consulting, accessed October 8, 2025, https://www.skyquestt.com/report/fluid-dispensing-systems-market/companies
26. Top Nordson MEDICAL Competitors and Alternatives | Craft.co, accessed October 8, 2025, https://craft.co/nordson-medical/competitors
27. ITW Test & Measurement and Electronics Business Overview, accessed October 8, 2025, https://www.itw.com/about-itw/business-segments/test-measurement-and-electronics/
28. Patents – Nordson, accessed October 8, 2025, https://www.nordson.com/en/divisions/electronics-solutions/patents
29. Nordson Corporation – Patented products and patents – IPRoduct, accessed October 8, 2025, https://iproduct.io/pages/company/nordson.com
30. Nordson Revenue 2010-2025 | NDSN – Macrotrends, accessed October 8, 2025, https://macrotrends.net/stocks/charts/NDSN/nordson/revenue
31. NORDSON CORPORATION – Annual Meeting & Proxy Statement, accessed October 8, 2025, https://s202.q4cdn.com/528247721/files/doc_financials/2022/ar/Nordson2023ProxyStatement.pdf
32. Nordson Corporation Reports Third Quarter Fiscal 2025 Results and Updates Full Year Guidance, accessed October 8, 2025, https://investors.nordson.com/news/news-details/2025/Nordson-Corporation-Reports-Third-Quarter-Fiscal-2025-Results-and-Updates-Full-Year-Guidance/
33. Nordson Corporation – Financials – Quarterly Results – Investor Relations, accessed October 8, 2025, https://investors.nordson.com/financials/quarterly-results/default.aspx
34. Nordson Corporation Reports Third Quarter Fiscal 2025 Results and Updates Full Year Guidance, accessed October 8, 2025, https://www.nordson.com/en/about-us/newsroom/corporate-news/nordson-corporation-reports-third-quarter-fiscal-2025-results-and-updates-full-year-guidance
35. R&D Expenses For Nordson Corporation (NDSN) – Finbox, accessed October 8, 2025, https://finbox.com/NASDAQGS:NDSN/explorer/rd_exp/
36. Nordson Corporation – News – Investor Relations, accessed October 8, 2025, https://investors.nordson.com/news/default.aspx
37. Nordson Corporation – Events & Presentations – Investor Relations, accessed October 8, 2025, https://investors.nordson.com/events-and-presentations/default.aspx
38. Nordson – 45 Year Stock Price History | NDSN – Macrotrends, accessed October 8, 2025, https://www.macrotrends.net/stocks/charts/NDSN/nordson/stock-price-history
39. Stock Info – Dividend History – Nordson Corporation, accessed October 8, 2025, https://investors.nordson.com/stock-info/dividend-history/default.aspx